ImmunityBio
IBRX
#3732
Rank
$1.65 B
Marketcap
$4.16
Share price
5.58%
Change (1 day)
N/A
Change (1 year)

Revenue for ImmunityBio (IBRX)

Revenue in 2022 (TTM): $0.8 M

According to ImmunityBio's latest financial reports the company's current revenue (TTM) is $0.8 M. In 2021 the company made a revenue of $0.93 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ImmunityBio from 2021 to 2022

Annual revenue

Year Revenue Change
2022 (TTM)$0.8 M-13.38%
2021$0.93 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/A-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA